MDCorp (MDCX) P/B (2016 - 2026)
MDCorp (MDCX) P/B from Feb 3, 2016 to Jul 21, 2026. The TTM MDCorp (MDCX) P/B is 11.66. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of MDCorp (MDCX)
| Year | P/B | Change |
|---|---|---|
| 2026 | 11.66 | -102.12% |
| 2025 | -550.28 | -6098.28% |
| 2024 | 9.17 | +535.56% |
| 2018 | 1.44 | +616.42% |
| 2017 | 0.20 | +346.67% |
| 2016 | 0.05 | N/A |
Comparison MDCorp (MDCX) P/B with competitors
MDCorp (MDCX) P/B is 11.66.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -94.13% |
| GRFS | Grifols SA | 0.79 | -93.22% |
| SNY | Sanofi | 1.27 | -89.11% |
| BIIB | Biogen Inc | 1.52 | -86.97% |
| PFE | Pfizer Inc | 1.55 | -86.72% |
| OGN | Organon & Company | 3.93 | -66.33% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -64.91% |
| GSK | GSK Plc | 4.37 | -62.50% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -48.19% |
| AZN | Astrazeneca plc | 6.20 | -46.82% |
| MRK | Merck & Co Inc | 6.68 | -42.70% |
| GILD | Gilead Sciences Inc | 6.94 | -40.47% |
| NVO | Novo Nordisk | 7.07 | -39.36% |
| NVS | Novartis AG | 7.60 | -34.81% |
| JNJ | Johnson & Johnson | 7.64 | -34.47% |
| NSRX | Nasus Pharma Ltd | 12.90 | +10.65% |
| AMGN | AMGEN Inc | 21.17 | +81.58% |
| SCLX | Scilex Holding Company | 28.85 | +147.45% |
| LLY | Lilly(Eli) & Company | 32.94 | +182.53% |
| ABBV | Abbvie Inc | 50.46 | +332.81% |